The human papillomavirus (HPV) accounts for 99.7% of all cervical cancer cases, and two strains of the virus – HPV 16 and 18 – are among the vaccine-preventable subtypes contributing to over 70% of all cervical cancer cases. Together, HPV subtypes (strains) also contribute to other cancers.
Unmasking the Silent Saboteur: How Misinformation Affected Kenya’s HPV Vaccine Uptake
